Your browser doesn't support javascript.
loading
Long term quality of life follow-up and functional impairment study in patients with Hirayama disease.
Zubair, Adeel S; Mustafa, Rafid; Crum, Brian.
Afiliação
  • Zubair AS; Yale University School of Medicine, Department of Neurology, New Haven, CT, USA.
  • Mustafa R; Mayo Clinic, Department of Neurology, Rochester, MN, USA.
  • Crum B; Mayo Clinic, Department of Neurology, Rochester, MN, USA. Electronic address: Crum.Brian@mayo.edu.
J Neurol Sci ; 459: 122952, 2024 Apr 15.
Article em En | MEDLINE | ID: mdl-38484554
ABSTRACT
Hirayama Disease (HD) is a focal motor neuron disorder generally affecting young adults with a male predominance who experience weakness and atrophy in distal upper extremity muscles in an asymmetric or unilateral pattern. Progression is insidious though significant weakness occurs during a progressive phase of the disease over 2-5 years. The long-term outcome of HD is not as well-known and, thus, this study presents self-reported outcomes from HD patients years after a diagnosis. Thirty HD patients reported quality of life (QOL) and other functional outcome measures after a mean of just over 11 years from diagnosis. Variables that predicted better or worse outcome were analyzed. Overall, QOL was affected by HD though most patients were functional with limitations. No clear attributes of patients or their disease predicted outcome.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Atrofias Musculares Espinais da Infância Limite: Adult / Female / Humans / Male Idioma: En Revista: J Neurol Sci Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Atrofias Musculares Espinais da Infância Limite: Adult / Female / Humans / Male Idioma: En Revista: J Neurol Sci Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos